Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Pro Encia Biotechnology announced it raised $1.51 Million in an initial filing from an offering of $2 Million
PRIVATEAug 26, 2026•about 3 hours ago
Amount Raised
$1.51 Million
Round Type
Seed
MinnesotaBiotechnologyHealth CareTherapeutics
Company Information
Company
ProEncia Biotechnology
Location
Minnesota, United States
About
ProEncia Biotechnology is an innovative biopharma startup co-founded in 2022, focused on advancing groundbreaking oral care solutions for patients suffering from periodontal disease. The company aims to develop easy-to-use, non-toxic, and non-invasive treatment options for all stages of the condition. Their pipeline includes novel, patent-pending products designed to meet the urgent need for innovation in periodontal care. ProEncia is committed to improving patient outcomes and expanding care options.
Don't miss ProEncia Biotechnology's next move
Get an email the moment ProEncia Biotechnology raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Predictive Intelligence
Strategic
ML-powered predictions for ProEncia Biotechnology's next move